Verticals / Pharma, medtech & health distribution / Abbott Laboratories
AL
Abbott Laboratories
abbott.com ↗—
Latest disclosed NPS
no score published
0
NPS entries
0 with a number
90%
Retention
16 Apr 2026
2026
Years covered
1 entries in all
In their words
“We are renewing contracts at a very high renewal rate—call it 90% plus”
NPS disclosures (0)
No NPS disclosures yet.
Retention disclosures (1)
16 Apr 2026
Retention90%
Retention rate (U.S. business): 90% (Q1 2026) — “We are renewing contracts at a very high renewal rate—call it 90% plus”
— Robert Ford, Chairman and Chief Executive Officer, Abbott Laboratories · Earnings call, Q1 2026 · 16 Apr 2026 · NI-E617D70
Earnings call, Q1 2026 ↗Lighthouse companies in Pharma, medtech & health distribution
About these figures
Every figure here was publicly disclosed by the named company: press releases, annual reports, SEC filings, earnings calls and news coverage. Companies tend to publish their NPS when it is good, so these numbers run higher than a true industry average: read them as what leading companies in this vertical say publicly, not as an industry benchmark.
NPS runs from −100 to +100. Retention figures are reported as the company defines them (net revenue retention, gross revenue retention, customer retention rate, churn). Every entry links to its source in the full database.